1-Methylpiperazine → HCID 59832200, compound
Reaction equation
[F:1][C:2]1[C:7]([F:8])=[CH:6][CH:5]=[CH:4][C:3]=1[CH2:9][C:10]([C:12]1[C:20]2[C:15](=[N:16][CH:17]=[C:18]([CH:21]3[CH2:23][CH:22]3[C:24]([OH:26])=O)[CH:19]=2)[NH:14][CH:13]=1)=[O:11].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH3:60][N:61]1[CH2:66][CH2:65][NH:64][CH2:63][CH2:62]1>CN(C=O)C>[F:1][C:2]1[C:7]([F:8])=[CH:6][CH:5]=[CH:4][C:3]=1[CH2:9][C:10]([C:12]1[C:20]2[C:15](=[N:16][CH:17]=[C:18]([C@@H:21]3[CH2:23][C@H:22]3[C:24]([N:64]3[CH2:65][CH2:66][N:61]([CH3:60])[CH2:62][CH2:63]3)=[O:26])[CH:19]=2)[NH:14][CH:13]=1)=[O:11]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
2-{3-[(2,3-Difluoro-phenyl)-acetyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-cyclopropanecarboxylic acid, (93 mg, 0.26 mmol), was combined with DIEA, (67 mg, 0.52 mmol), and HBTU, (113 mg, 0.3 mmol) in 1 mL DMF and stirred at rt for ˜15 min. Then N-methyl piperazine, (26 mg, 0.26 mmol), was added and the reaction stirred at rt for 4 hours. The DMF was evaporated under vacuum, water added and the suspension extracted with dichloromethane. The solvent was evaporated under vacuum and the residue purified by silica chromatography, (eluent: 5% methanol/DCM), affording trans-2-(2,3-Difluoro-phenyl)-1-{5-[2-(4-methyl-piperaz ine-1-carbonyl)-cyclopropyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}-ethanone, (35 mg, Rf 0.5) and the cis isomer (16 mg, Rf 0.3).
Workup
- stirringthe reaction stirred at rt for 4 hours
- customThe DMF was evaporated under vacuum, water
- additionadded
- extractionthe suspension extracted with dichloromethane
- customThe solvent was evaporated under vacuum
- customthe residue purified by silica chromatography, (eluent: 5% methanol/DCM),
Sources & evidence
- ORD record
- ord-6040e632d19b42a2a26bc3ce59f48caf
- Source dataset
- uspto-grants-2008_11
- Patent number
- US07446199B2
Reaction notes
Loading…